Resistance is not the most concerning aspect of antibiotics, despite it being the most covered in the news. We need to be moving away from antibiotics.

https://humanmicrobiome.info/antibiotics/#harms-of-antibiotics

A new class of antibiotics is offering real hope of a response to the problem of antimicrobial resistance, hitting bacteria with a dual-pronged assault that’s almost impossible to combat. Called macrolones, the drugs target two bacterial processes simultaneously – and the scientists behind a new study say this makes evolving resistance 100 million times more difficult.